|
N
|
735
|
49
| |
712
|
72
| |
|
Male sex (%)
|
53.8
|
69.4
|
0.03
|
53.7
|
70.8
|
0.005
|
|
Age (years)
|
42.6 ± 11.0
|
52.3 ± 12.5
|
<0.0001
|
42.7 ± 11.1
|
49.5 ± 12.6
|
<0.0001
|
|
Duration of diabetes (years)
|
27.1 ± 9.0
|
33.3 ± 11.6
|
0.0004
|
27.2 ± 9.1
|
31.3 ± 10.6
|
0.004
|
|
Body mass index (kg/m2)
|
24.2 ± 3.5
|
24.9 ± 3.7
|
0.24
|
24.4 ± 3.5
|
23.6 ± 3.8
|
0.07
|
|
Systolic blood pressure (mmHg)
|
134 ± 19
|
144 ± 21
|
0.0007
|
134 ± 19
|
142 ± 18
|
0.0005
|
|
Diastolic blood pressure (mmHg)
|
77 ± 11
|
80 ± 11
|
0.07
|
76 ± 11
|
80 ± 10
|
0.004
|
|
HbA1c (%) and (mmol/mol)
|
8.5 ± 1.5 (70 ± 16)
|
8.9 ± 1.5 (74 ± 16)
|
0.08
|
8.5 ± 1.4 (69 ± 15)
|
9.4 ± 2.3 (79 ± 25)
|
<0.0001
|
|
Urinary albumin excretion (mg/l)
|
21 (177)
|
43 (836)
|
0.22
|
19 (157)
|
188 (900)
|
<0.0001
|
|
eGFR (ml/min)
|
86 ± 47
|
70 ± 31
|
0.02
|
86 ± 46
|
69 ± 56
|
<0.0001
|
|
Total cholesterol* (mmol/l)
|
5.67 ± 1.51
|
5.91 ± 1.07
|
0.28
|
5.65 ± 1.42
|
5.76 ± 1.67
|
0.97
|
|
Lipids lowering therapy (%)
|
7.9
|
16.3
|
0.04
|
8.3
|
11.1
|
0.41
|
|
Tobacco smoking (%)
|
42.0
|
47.9
|
0.42
|
41.2
|
59.2
|
0.004
|
|
Arterial hypertension (%)
|
60.8
|
83.7
|
0.001
|
60.5
|
84.7
|
<0.0001
|
|
Previous myocardial infarction (%)
|
3.8
|
22.9
|
<0.0001
|
3.9
|
21.1
|
<0.0001
|
